SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-008587
Filing Date
2010-02-04
Accepted
2010-02-04 10:32:24
Documents
3
Period of Report
2010-02-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g21997e8vk.htm 8-K 12346
2 EX-99.1 g21997exv99w1.htm EX-99.1 42903
3 GRAPHIC g21997biocryst.gif GRAPHIC 4336
  Complete submission text file 0000950123-10-008587.txt   62948
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 10572825
SIC: 2836 Biological Products, (No Diagnostic Substances)